Literature DB >> 20329498

Anti alpha-gal immune response following porcine bioprosthesis implantation in children.

Chun Soo Park1, Seong-Sik Park, Sun Young Choi, Sun Hee Yoon, Woong-Han Kim, Yong Jin Kim.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Porcine bioprostheses have been widely used in cardiac surgery in the treatment of valvular heart disease. However, in younger patients, their use has been limited by early failures known to be associated with an immune response and subsequent degeneration. The natural antibodies directed at Galalpha1, 3-Galbeta1-4GlcNAc-R(alpha-Gal), have been thought to initiate an immune response in humans transplanted with porcine organ xenografts. The study aim was to determine the anti alpha-Gal immune response following commercial porcine bioprosthesis implantation in children.
METHODS: Between January 2008 and April 2008, 19 consecutive patients underwent pulmonary valve replacement (PVR) with a commercially available porcine bioprosthesis for an incompetent pulmonary valve with congenital heart diseases. The median age at surgery was 132 months (range: 14-330 months). Previous PVR with a porcine bioprosthesis had been performed in seven patients at a median of 44 months (range: 26-117 months) before surgery (re-PVR group). Sera were obtained sequentially five times: immediately before surgery, and at one day, one week, three weeks, and two months postoperatively. All serum samples were analyzed using an enzyme-linked immunosorbent assay to investigate the alpha-Gal immune response.
RESULTS: There were no operative deaths or complications. There was no statistically significant difference between the titers of anti alpha-Gal antibodies of the PVR and re-PVR groups. The titer of anti alpha-Gal antibodies (IgM and IgG) was decreased on the first postoperative day, but increased in the first postoperative week, regardless of the isotype. Whilst the titer of the anti alpha-Gal IgM antibody began to decrease after three weeks postoperatively, the titer of anti alpha-Gal IgG antibody remained increased after two months.
CONCLUSION: The implantation of a porcine bioprosthesis elicits the increased formation of anti alpha-Gal antibodies during the early postoperative period in children, with different patterns between the two isotypes. The IgM antibody response was rapid and transient, while the IgG antibody response was longer and more delayed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20329498

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  16 in total

1.  Mid- to long-term outcomes of bovine jugular vein conduit implantation in Chinese children.

Authors:  Hui-Feng Zhang; Gang Chen; Ming Ye; Xian-Gang Yan; Qi-Lin Tao; Bing Jia
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 2.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

Review 3.  Bioprosthetic heart valves of the future.

Authors:  Rizwan A Manji; Burcin Ekser; Alan H Menkis; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-01-21       Impact factor: 3.907

4.  Effect of Urea and Thiourea on Generation of Xenogeneic Extracellular Matrix Scaffolds for Tissue Engineering.

Authors:  Maelene L Wong; Janelle L Wong; Rebecca M Horn; Kimberley C Sannajust; Dawn A Rice; Leigh G Griffiths
Journal:  Tissue Eng Part C Methods       Date:  2016-06-27       Impact factor: 3.056

Review 5.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Changes of the Structural and Biomechanical Properties of the Bovine Pericardium after the Removal of α-Gal Epitopes by Decellularization and α-Galactosidase Treatment.

Authors:  Jinhae Nam; Sun-Young Choi; Si-Chan Sung; Hong-Gook Lim; Seong-Sik Park; Soo-Hwan Kim; Yong Jin Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-12-07

7.  Surgical management of chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction.

Authors:  Cheul Lee
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

8.  A Durable Porcine Pericardial Surgical Bioprosthetic Heart Valve: a Proof of Concept.

Authors:  Benyamin Rahmani; Christopher McGregor; Guerard Byrne; Gaetano Burriesci
Journal:  J Cardiovasc Transl Res       Date:  2019-02-12       Impact factor: 4.132

Review 9.  N-Glycolylneuraminic Acid (Neu5Gc) Null Large Animals by Targeting the CMP-Neu5Gc Hydroxylase (CMAH).

Authors:  Andrea Perota; Cesare Galli
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

10.  Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.

Authors:  Christopher McGregor; Guerard Byrne; Benyamin Rahmani; Elisa Chisari; Konstantina Kyriakopoulou; Gaetano Burriesci
Journal:  Acta Biomater       Date:  2016-06-04       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.